|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.10 GBX | -1.97% |
|
-2.12% | -3.69% |
| 01-09 | Life Science REIT portfolio value drops | AN |
| 01-09 | Berenberg raises M&S; BofA cuts Barratt Redrow | AN |
| Fiscal Period: October | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 678M | 787M | 914M | 658M | 618M | |||||
Total Revenues | 678M | 787M | 914M | 658M | 618M | |||||
Cost of Goods Sold, Total | 570M | 620M | 719M | 557M | 556M | |||||
Gross Profit | 108M | 167M | 194M | 101M | 61.8M | |||||
Selling General & Admin Expenses, Total | 53.3M | 49.5M | 50.8M | 54M | 60.2M | |||||
Provision for Bad Debts | - | - | - | 600K | 600K | |||||
Other Operating Expenses | - | - | - | 800K | -7M | |||||
Other Operating Expenses, Total | 53.3M | 49.5M | 50.8M | 55.4M | 53.8M | |||||
Operating Income | 54.4M | 117M | 144M | 45.2M | 8M | |||||
Interest Expense, Total | -13.6M | -11.6M | -11.2M | -14.2M | -18.9M | |||||
Interest And Investment Income | 3.4M | 3.4M | 2.8M | 3.6M | 3.4M | |||||
Net Interest Expenses | -10.2M | -8.2M | -8.4M | -10.6M | -15.5M | |||||
Income (Loss) On Equity Invest. | -500K | 1.7M | 2.5M | 3.3M | -100K | |||||
Other Non Operating Income (Expenses) | - | -1M | -2.3M | - | - | |||||
EBT, Excl. Unusual Items | 43.7M | 110M | 135M | 37.9M | -7.6M | |||||
Restructuring Charges | -7.5M | - | - | -500K | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | -1.6M | |||||
Gain (Loss) On Sale Of Investments | -7.9M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | -1.1M | |||||
Asset Writedown | -43.2M | 8M | - | - | -5.7M | |||||
Legal Settlements | - | - | - | -13M | -400K | |||||
Other Unusual Items | 1.4M | -30.8M | -102M | -1.3M | -127M | |||||
EBT, Incl. Unusual Items | -13.5M | 86.9M | 32.8M | 23.1M | -144M | |||||
Income Tax Expense | -2.8M | 16M | 6.4M | 5.2M | -40.2M | |||||
Earnings From Continuing Operations | -10.7M | 70.9M | 26.4M | 17.9M | -104M | |||||
Net Income to Company | -10.7M | 70.9M | 26.4M | 17.9M | -104M | |||||
Net Income - (IS) | -10.7M | 70.9M | 26.4M | 17.9M | -104M | |||||
Net Income to Common Incl Extra Items | -10.7M | 70.9M | 26.4M | 17.9M | -104M | |||||
Net Income to Common Excl. Extra Items | -10.7M | 70.9M | 26.4M | 17.9M | -104M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.04 | 0.28 | 0.1 | 0.07 | -0.4 | |||||
Basic EPS - Continuing Operations | -0.04 | 0.28 | 0.1 | 0.07 | -0.4 | |||||
Basic Weighted Average Shares Outstanding | 257M | 257M | 256M | 256M | 256M | |||||
Net EPS - Diluted | -0.04 | 0.27 | 0.1 | 0.07 | -0.4 | |||||
Diluted EPS - Continuing Operations | -0.04 | 0.27 | 0.1 | 0.07 | -0.4 | |||||
Diluted Weighted Average Shares Outstanding | 257M | 258M | 258M | 257M | 256M | |||||
Normalized Basic EPS | 0.11 | 0.27 | 0.33 | 0.09 | -0.02 | |||||
Normalized Diluted EPS | 0.11 | 0.27 | 0.33 | 0.09 | -0.02 | |||||
Dividend Per Share | - | 0.14 | 0.17 | 0.17 | 0.02 | |||||
Payout Ratio | - | 14.81 | 145.83 | 243.58 | -31.01 | |||||
American Depositary Receipts Ratio (ADR) | 2 | 2 | 2 | 2 | 2 | |||||
Supplemental Items | ||||||||||
EBITDA | 58.8M | 118M | 144M | 45.7M | 8.4M | |||||
EBITA | 54.4M | 117M | 144M | 45.2M | 8M | |||||
EBIT | 54.4M | 117M | 144M | 45.2M | 8M | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 20.74 | 18.41 | 19.51 | 22.51 | 27.97 | |||||
Current Domestic Taxes | -3.5M | 11.6M | 6.1M | 3.5M | -4.2M | |||||
Total Current Taxes | -3.5M | 11.6M | 6.1M | 3.5M | -4.2M | |||||
Deferred Domestic Taxes | 700K | 4.4M | 300K | 1.7M | -36M | |||||
Total Deferred Taxes | 700K | 4.4M | 300K | 1.7M | -36M | |||||
Normalized Net Income | 27.31M | 68.56M | 84.56M | 23.69M | -4.75M | |||||
Interest on Long-Term Debt | 900K | 900K | 800K | 800K | 1.1M | |||||
Non-Cash Pension Expense | 500K | 900K | 600K | 100K | 100K | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 52.8M | 47.8M | 50.2M | 53.9M | 60.1M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 500K | 1.8M | 1.9M | 1.5M | 1.8M | |||||
Total Stock-Based Compensation | 500K | 1.8M | 1.9M | 1.5M | 1.8M |
- Stock Market
- Equities
- CRST Stock
- Financials Crest Nicholson Holdings plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















